GulfDrug celebrates 50 years of care, trust and commitment of providing for and growing with health institutions in the UAE

Fast forward a few decades, the company has entered 2020 with a comprehensive group of healthcare technology and innovation leaders, branched via its various divisions, and has big growth plans

  
GulfDrug celebrates 50 years of care, trust and commitment of providing for and growing with health institutions in the UAE

Dubai, United Arab Emirates: Established in 1969 and tied to the early history of healthcare in the UAE, GulfDrug LLC marks its 50th anniversary as a premier provider of healthcare products, services, and solutions in the country. Fast forward a few decades, the company has entered 2020 with a comprehensive group of healthcare technology and innovation leaders, branched via its various divisions, and has big growth plans.

Starting off as an ancillary pharmacy to a small private clinic, Dr. Hassan Al Moosa Private Clinic, in the once ‘downtown’ area of Bur Dubai in the late ’60s, GulfDrug is one of the earliest medical establishments within the UAE and has since grown into a large corporation offering the most comprehensive solutions to the healthcare market. Since its inception, the company has expanded and grown from being a small-scale pharmaceutical provider to now importing high technology medical equipment, instruments and disposables growing their product portfolio and progressing side by side with the development, growth, and maturity of various health institutions in the UAE. This development has allowed GulfDrug to be one the most reliable partners and solution providers for medical institutions in the Middle East and is now celebrating 50 successful years of quality service.

In 1969, the Founder Late Dr. Hassan Al Moosa saw great potential growth opportunities and room for development in the medical industry and launched Gulf Pharmacy/GulfDrug after just one year into being established. The company began importing pharmaceuticals, medical disposables, and instruments for various institutions. In the 1980s, GulfDrug entered a new market within healthcare with the beginning of high-tech medequip imports, and expanding range of pharma, medical disposables & devices.

In 1996, the GulfDrug family saw the early demise of the founder and the company board passed down the leadership to the sons of Late Dr. Hassan Al Moosa, Dr. Zeyad Al Moosa and Mr. Rashad Al Moosa. Under new management, and in line with their father’s vision, GulfDrug continued pursuing a strategy of investing in all healthcare segments it served with its specialized business units’ structures. GulfDrug has since expanded its client services to include turnkey biomedical facility maintenance services, project management and expanded to outsourcing clinical services locally and regionally.

With the trust and faith of its customers and the professional support from its suppliers, GulfDrug has been able to grow tremendously through the years within hospitals, clinics, and pharmacies, and hopes to continue making strides in the medical industry and provide top quality services to its customers. As GulfDrug continues to work on new projects, the company’s vision and main objective is to be the customer’s preferred provider of products, services, and solutions to the healthcare industry they serve and improve healthcare outcomes and services in the UAE. 

—Ends-

For media enquiries
Victoria Saldungaray
Empyre Communications
victoria@empyrecommunications.com
+971 50 829 1122

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.


More From Press Releases